Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties

Sergey Deyev, Anzhelika Vorobyeva, Alexey Schulga, Galina Proshkina, Rezan Güler, John Löfblom, Bogdan Mitran, Javad Garousi, Mohamed Altai, Jos Buijs, Vladimir Chernov, Anna Orlova, Vladimir Tolmachev

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins that can be selected for binding to desirable molecular targets. High affinity and small size of DARPins render them promising probes for radionuclide molecular imaging. However, detailed knowledge on many factors influencing their imaging properties is still lacking. We have evaluated two human epidermal growth factor 2 (HER2)-specific DARPins with different size and binding properties. DARPins 9-29-H 6 and G3-H 6 were radiolabeled with iodine-125 and tricarbonyl technetium-99m and evaluated in vitro. A side-by-side comparison of biodistribution and tumor targeting was performed. HER2-specific tumor accumulation of G3-H 6 was demonstrated. A combination of smaller size and higher affinity resulted in a higher tumor uptake of G3-H 6 in comparison to 9-29-H 6 . Technetium-99m labeled G3-H 6 demonstrated a better biodistribution profile than 9-29-H 6 , with several-fold lower uptake in liver. Radioiodinated G3-H 6 showed the best tumor-to-organ ratios. The combined effect of affinity, molecular weight, scaffold composition, and nonresidualizing properties of iodine label provided radioiodinated G3-H 6 with high clinical potential for imaging of HER2.

Original languageEnglish
JournalMolecular Pharmaceutics
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Affinity Labels
Ankyrin Repeat
Epidermal Growth Factor
Technetium
Neoplasms
Proteins
Iodine
Molecular Imaging
Radionuclide Imaging
Molecular Weight
Liver

Keywords

  • DARPin
  • I-125
  • imaging
  • radionuclide
  • targeting
  • Tc-99m

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Comparative Evaluation of Two DARPin Variants : Effect of Affinity, Size, and Label on Tumor Targeting Properties. / Deyev, Sergey; Vorobyeva, Anzhelika; Schulga, Alexey; Proshkina, Galina; Güler, Rezan; Löfblom, John; Mitran, Bogdan; Garousi, Javad; Altai, Mohamed; Buijs, Jos; Chernov, Vladimir; Orlova, Anna; Tolmachev, Vladimir.

In: Molecular Pharmaceutics, 01.01.2019.

Research output: Contribution to journalArticle

Deyev, S, Vorobyeva, A, Schulga, A, Proshkina, G, Güler, R, Löfblom, J, Mitran, B, Garousi, J, Altai, M, Buijs, J, Chernov, V, Orlova, A & Tolmachev, V 2019, 'Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties', Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.8b00922
Deyev, Sergey ; Vorobyeva, Anzhelika ; Schulga, Alexey ; Proshkina, Galina ; Güler, Rezan ; Löfblom, John ; Mitran, Bogdan ; Garousi, Javad ; Altai, Mohamed ; Buijs, Jos ; Chernov, Vladimir ; Orlova, Anna ; Tolmachev, Vladimir. / Comparative Evaluation of Two DARPin Variants : Effect of Affinity, Size, and Label on Tumor Targeting Properties. In: Molecular Pharmaceutics. 2019.
@article{827ded3ad5e440e3b5ff182c6cfcb0a8,
title = "Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties",
abstract = "Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins that can be selected for binding to desirable molecular targets. High affinity and small size of DARPins render them promising probes for radionuclide molecular imaging. However, detailed knowledge on many factors influencing their imaging properties is still lacking. We have evaluated two human epidermal growth factor 2 (HER2)-specific DARPins with different size and binding properties. DARPins 9-29-H 6 and G3-H 6 were radiolabeled with iodine-125 and tricarbonyl technetium-99m and evaluated in vitro. A side-by-side comparison of biodistribution and tumor targeting was performed. HER2-specific tumor accumulation of G3-H 6 was demonstrated. A combination of smaller size and higher affinity resulted in a higher tumor uptake of G3-H 6 in comparison to 9-29-H 6 . Technetium-99m labeled G3-H 6 demonstrated a better biodistribution profile than 9-29-H 6 , with several-fold lower uptake in liver. Radioiodinated G3-H 6 showed the best tumor-to-organ ratios. The combined effect of affinity, molecular weight, scaffold composition, and nonresidualizing properties of iodine label provided radioiodinated G3-H 6 with high clinical potential for imaging of HER2.",
keywords = "DARPin, I-125, imaging, radionuclide, targeting, Tc-99m",
author = "Sergey Deyev and Anzhelika Vorobyeva and Alexey Schulga and Galina Proshkina and Rezan G{\"u}ler and John L{\"o}fblom and Bogdan Mitran and Javad Garousi and Mohamed Altai and Jos Buijs and Vladimir Chernov and Anna Orlova and Vladimir Tolmachev",
year = "2019",
month = "1",
day = "1",
doi = "10.1021/acs.molpharmaceut.8b00922",
language = "English",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Comparative Evaluation of Two DARPin Variants

T2 - Effect of Affinity, Size, and Label on Tumor Targeting Properties

AU - Deyev, Sergey

AU - Vorobyeva, Anzhelika

AU - Schulga, Alexey

AU - Proshkina, Galina

AU - Güler, Rezan

AU - Löfblom, John

AU - Mitran, Bogdan

AU - Garousi, Javad

AU - Altai, Mohamed

AU - Buijs, Jos

AU - Chernov, Vladimir

AU - Orlova, Anna

AU - Tolmachev, Vladimir

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins that can be selected for binding to desirable molecular targets. High affinity and small size of DARPins render them promising probes for radionuclide molecular imaging. However, detailed knowledge on many factors influencing their imaging properties is still lacking. We have evaluated two human epidermal growth factor 2 (HER2)-specific DARPins with different size and binding properties. DARPins 9-29-H 6 and G3-H 6 were radiolabeled with iodine-125 and tricarbonyl technetium-99m and evaluated in vitro. A side-by-side comparison of biodistribution and tumor targeting was performed. HER2-specific tumor accumulation of G3-H 6 was demonstrated. A combination of smaller size and higher affinity resulted in a higher tumor uptake of G3-H 6 in comparison to 9-29-H 6 . Technetium-99m labeled G3-H 6 demonstrated a better biodistribution profile than 9-29-H 6 , with several-fold lower uptake in liver. Radioiodinated G3-H 6 showed the best tumor-to-organ ratios. The combined effect of affinity, molecular weight, scaffold composition, and nonresidualizing properties of iodine label provided radioiodinated G3-H 6 with high clinical potential for imaging of HER2.

AB - Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins that can be selected for binding to desirable molecular targets. High affinity and small size of DARPins render them promising probes for radionuclide molecular imaging. However, detailed knowledge on many factors influencing their imaging properties is still lacking. We have evaluated two human epidermal growth factor 2 (HER2)-specific DARPins with different size and binding properties. DARPins 9-29-H 6 and G3-H 6 were radiolabeled with iodine-125 and tricarbonyl technetium-99m and evaluated in vitro. A side-by-side comparison of biodistribution and tumor targeting was performed. HER2-specific tumor accumulation of G3-H 6 was demonstrated. A combination of smaller size and higher affinity resulted in a higher tumor uptake of G3-H 6 in comparison to 9-29-H 6 . Technetium-99m labeled G3-H 6 demonstrated a better biodistribution profile than 9-29-H 6 , with several-fold lower uptake in liver. Radioiodinated G3-H 6 showed the best tumor-to-organ ratios. The combined effect of affinity, molecular weight, scaffold composition, and nonresidualizing properties of iodine label provided radioiodinated G3-H 6 with high clinical potential for imaging of HER2.

KW - DARPin

KW - I-125

KW - imaging

KW - radionuclide

KW - targeting

KW - Tc-99m

UR - http://www.scopus.com/inward/record.url?scp=85061542501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061542501&partnerID=8YFLogxK

U2 - 10.1021/acs.molpharmaceut.8b00922

DO - 10.1021/acs.molpharmaceut.8b00922

M3 - Article

AN - SCOPUS:85061542501

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

ER -